Angiographic Features of Atherosclerotic Superficial Femoral Artery Disease in Diabetics and Non-diabetics Presenting with Claudication Atif Mohammad,

Slides:

Advertisements

Similar presentations

Case presentation: Critical Limb Ischemia

Advertisements

Single Center Experience with Drug Eluting Stents for Infrapopliteal Occlusive Disease in Patients with Critical Limb Ischemia: Mid-term follow up Robert.

COBRA Trial COBRA Trial Cryoplasty or Conventional Balloon Post-dilation of Nitinol Stents For Revascularization of Peripheral Arterial Segments Subhash.

Superficial Femoral Artery Stents - Bare, Covered, or Drug-Coated – “The Data and The HYPE” Dennis F. Bandyk, MD Division of Vascular & Endovascular Surgery.

FAST (Femoral Artery Stenting Trial) Final Results Hans Krankenberg (on behalf of the FAST Investigators) Hamburg University Cardiovascular Center Prof.

Aspirin Plus Coumarin Versus Aspirin Alone in the Prevention of Reocclusion After Fibrinolysis for Acute Myocardial Infarction Results of the Antithrombotics.

1 1 The Use of Percutaneous Coronary Intervention in Patients with Class I Indications for Coronary Artery Bypass Graft Surgery: Data from the National.

® From Bad to Worse: Comorbidities and Chronic Lower Back Pain Margaret Cecere JD, Richard Young MD, Sandra Burge PhD The University of Texas Health Science.

Endarterectomy versus Stenting in Patients with Symptomatic Severe Carotid Stenosis Dr. Quan, Dr. Mirhashemi, Dr. Chiang N Engl J Med 2006; 355:

Surgical approach of aortic valve disease associated with coronary artery disease Al Hussein Hussam Cernica D.R., Al Hussein S.M., Bud I.T., Ceteras D.M.

Problem: Studies suggest that primary care physician-patient encounters are characterized by competing demands that force clinicians to prioritize and.

Are efforts to improve technical quality of care competing with improving clinical outcomes?: The case of the elevated A1c Parchman ML, Pugh JA, Romero.

Wins/Losses and Errors/Ties: Quality of Care for Acute Myocardial Infarction in the VA Health Care System Laura A. Petersen, M.D., M.P.H. 1 Sharon-Lise.

LONG-TERM OUTCOMES OF PERCUTANEOUS CORONARY INTERVENTION FOR UNPROTECTED LEFT MAIN CORONARY ARTERY DISEASE: INITIAL CLINICAL EXPERIENCE. Graidis Ch. 1,

Do veterans with spinal cord injury and diabetes have greater risk of macrovascular complications? Ranjana Banerjea, PhD 1, Usha Sambamoorthi, PhD 1,2,3,

12-Month Analysis Barry T. Katzen MD, FACR, FACC Founder and Medical Director Baptist Cardiac & Vascular Institute.

A Prospective, Randomized Trial Evaluating a Paclitaxel-Eluting Balloon in Patients TReated with Endothelial Progenitor Cell CapTuring Stents for De Novo.

Endovascular Treatment of Atherosclerotic Popliteal Artery Lesions – Balloon Angioplasty versus primary Stenting: A prospective, multi-centre, randomised.

: PROFI : A Prospective, Randomized Trial of Proximal Balloon Occlusion vs. Filter Embolic Protection in Patients Undergoing Carotid Stenting Klaudija.

Clinical and Economic Benefits Associated With the Achievement of Both HbA1c and LDL Cholesterol Goals in Veterans With Type 2 Diabetes Featured Article:

Integrated Care for Veterans with Diabetes & Serious Mental Illness Judith A. Long, MD Steven C. Marcus, PhD.

Is there any role for intravascular ultrasound in bifurcation lesions? Giuseppe Biondi-Zoccai, MD University of Turin, Turin, Italy.

The GREAT Trial. The Grampian Region Early Anistreplase Trial Reference Zahringer M, Sapoval M, Pattynama PM, et al. Sirolimus-eluting versus bare-metal.

When Using DOPPS Slides. DOPPS Slide Use Guidelines.

Date of download: 7/7/2016 Copyright © The American College of Cardiology. All rights reserved. From: Pilot Trial of Cryoplasty or Conventional Balloon.

Dr. Quan, Dr. Mirhashemi, Dr. Chiang

Predictors of restenosis in the use of helical interwoven nitinol stents to treat femoropopliteal occlusive disease Yiu Che Chan, MBBS, MD, FRCS, Stephen.

Peripheral Artery Advanced SFA-CTO Techniques in the

Harvard Clinical Research Institute, Boston, US

Lutonix® Paclitaxel-Coated Balloon to Treat Obstructive Lesions in the Superficial Femoral and Popliteal Arteries Preliminary Six-Month Results from.

Table 1: Table 2: Non Therapeutic Angiograms in Acute Ischemic Stroke Patients Being Considered for Endovascular Treatment Does not Adversely Affect Patient.

The BVS-SAVE Italian registry: Bioresorbable Vascular Scaffolds

Treating Infrapopliteal Disease Using a Primarily Retrograde Technique

Magnetic Resonance Imaging-derived Arterial Peak Flow in Peripheral Arterial Disease: Towards a Standardized Measurement B. Versluis, P.J. Nelemans,

Ipsilateral Cerebral Venous Outflow Obstruction Is Associated with Fatal Edema of MCA Infarction Wengui Yu, Joanna Rives, Babu Welch, Jonathan White,

Angiographic Features of Atherosclerotic Superficial Femoral Artery Disease in Diabetics and Non-diabetics Presenting with Claudication Atif Mohammad,

History : Case June 18’ year old male patient with complaints of life style limiting claudication symptoms in right leg at rest (Rutherford Grade.

How Available is Health Care?

Successful CTO PCI Associated with Lower Mortality Risk

LONG-DES II Trial Randomized Comparison of the Efficacy of Sirolimus-Eluting Stent Versus Paclitaxel-Eluting Stent in the Treatment of Long Native Coronary.

History : Case March 26, year old male patient with complaints of left calf pain (Typical Claudication) at rest and on exertion (Fontaine II/B).

Case presentation: Critical Limb Ischemia

Excimer Laser Atherectomy for the Treatment of Infra-inguinal Peripheral Arterial Disease Bryan P Yan MD, Thomas J Kiernan MD, Vishal Gupta MD,

Veterans Affairs Program Brief

Percutaneous Reconstruction of the Aortoiliac Bifurcation

Predictors of restenosis in the use of helical interwoven nitinol stents to treat femoropopliteal occlusive disease Yiu Che Chan, MBBS, MD, FRCS, Stephen.

(A) This drawing illustrates axillobifemoral bypass, with a distal extension to the popliteal artery. This patient had severe ischemic change in right.

Pilot safety study of perivascular injection of tissue-engineered allogeneic aortic endothelial cells in patients undergoing minimally invasive peripheral.

Predictors of restenosis in the use of helical interwoven nitinol stents to treat femoropopliteal occlusive disease Yiu Che Chan, MBBS, MD, FRCS, Stephen.

Gait Biomechanics in Patients with Peripheral Artery Disease After Revascularization Sarah Bakera, Sara A. Myersa,c, Iraklis Pipinosb,c, and Jason Johanningb,c.

FAIR Trial design: Patients with SFA in-stent restenosis (ISR) were randomized to either a paclitaxel-coated balloon (DCB) (dose 3.5 μg/mm2) or routine.

Daniel B. Walsh, MD, Richard J. Powell, MD, Therese A. Stukel, PhD, E

Giuseppe Biondi Zoccai, MD

First clinical trial of nitinol self-expanding everolimus-eluting stent implantation for peripheral arterial occlusive disease Johannes Lammer, MD, Marc.

Role of simple and complex hybrid revascularization procedures for symptomatic lower extremity occlusive disease Hasan H. Dosluoglu, MD, Purandath Lall,

ILLUMENATE Trial design: Patients with superficial femoral artery (SFA) and/or popliteal arterial stenoses were randomized in a 2:1 fashion to either balloon.

Endovascular treatment of long lesions of the superficial femoral artery: Results from a multicenter registry of a spiral, covered polytetrafluoroethylene.

Magnetic Resonance Imaging Characteristics of Peripheral Arterial Lesions Relate to the Difficulty of Endovascular Procedures Trisha L. Roy, BASc, MD,

(p < 0.05 for paclitaxel angioplasty vs. either control)

“Better” (sometimes) in vascular disease management

Long-term results of a multicenter randomized study on direct versus crossover bypass for unilateral iliac artery occlusive disease Jean-Baptiste Ricco,

Impact of Diabetes Mellitus on Long-term Outcomes in the

Endovascular treatment of atherosclerotic popliteal artery disease based on dynamic angiography findings Chaoyi Cui, MD, PhD, Xintian Huang, MD, Xiaobing.

Vascular Surgery Michael Ricci, MD.

Results of a randomized clinical trial of external beam radiation to prevent restenosis after superficial femoral artery stenting Eric Therasse, MD,

Lower-extremity complications with femoral extracorporeal life support

High incidence of restenosis/reocclusion of stents in the percutaneous treatment of long-segment superficial femoral artery disease after suboptimal angioplasty

Ronald L. Dalman, MD, Lloyd M. Taylor, MD, Gregory L

Axillary-Bi-Femoral and Axillary-Uni-Femoral Artery Grafts Have Similar Perioperative Outcomes and Patency Thomas W. Cheng1, M.S., Scott Hardouin1, M.D.,

Thigh claudication due to profunda femoris artery occlusion

Presentation transcript:

Angiographic Features of Atherosclerotic Superficial Femoral Artery Disease in Diabetics and Non-diabetics Presenting with Claudication Atif Mohammad, MD Research Fellow VA North Texas Health Care System UT Southwestern Medical Center Dallas,TX On behalf of the investigators:

INVESTIGATORS Atif Mohammad, MD *† Avantika Banerjee * Omar Hadidi, MD † Gene Pershwitz, MD * Mirza Baig, MD *† Emmanouil S. Brilakis, MD, PhD *† * VA North Texas Health Care System, Dallas, TX; † University of Texas Southwestern Medical Center, Dallas, TX; Acknowledgements: Dallas VA Research Corporation

BACKGROUND & METHOD Though clinical outcomes following percutaneous revascularization of superficial femoral artery (SFA) varies between diabetics (DM) and non-diabetics, angiographic differences of their SFA disease has never been systemically analyzed We conducted blinded angiographic analysis of peripheral angiograms in 117 consecutive patients (79 DM and 38 non-DM) between January January 2011, presenting to Veterans Affairs Haelth Care System (Veterans Integrated Service Network or VISN 17) with Rutherford category 3 claudication

METHOD: ANGIOGRAPHIC ANALYSIS

BOLLINGER SCORE

RESULTS: Mean Bollinger Scores p=0.03 Non-DM DM

RESULTS: SFA: superficial femoral artery

RESULTS: Angiographic Distribution of SFA in Diabetics & Non-Diabetics n=78 n=39 SFA: superficial femoral artery

RESULTS: Lesion Flow & Stenosis Characteristics in Diabetics & Non-Diabetics

RESULTS: Lesion Characteristics & Revascularization in Diabetics & Non-Diabetics

RESULTS: Procedural Complications & Outcomes in Diabetics & Non-Diabetics

CONCLUSIONS: These results indicate the greater severity of SFA disease in patients with diabetes mellitus, increased need for stenting & lower 12 month patency Our findings also indicate to the need for dedicated strategies for improving outcomes in diabetics with peripheral arterial disease undergoing endovascular revascularization procedures for life- style limiting claudication SFA: superficial femoral artery